Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EBITDA: 2019-2024

Historic EBITDA for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $282.0 million.

  • Cellebrite DI's EBITDA fell 90.38% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.4 million, marking a year-over-year decrease of 75.27%. This contributed to the annual value of $282.0 million for FY2024, which is 250.79% up from last year.
  • Latest data reveals that Cellebrite DI reported EBITDA of $282.0 million as of FY2024, which was up 250.79% from $80.4 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's EBITDA ranged from a high of $282.0 million in FY2024 and a low of $9.2 million during FY2020.
  • Over the past 3 years, Cellebrite DI's median EBITDA value was $119.8 million (recorded in 2022), while the average stood at $160.7 million.
  • As far as peak fluctuations go, Cellebrite DI's EBITDA spiked by 819.59% in 2020, and later tumbled by 32.88% in 2023.
  • Yearly analysis of 5 years shows Cellebrite DI's EBITDA stood at $9.2 million in 2020, then skyrocketed by 49.95% to $13.8 million in 2021, then soared by 766.47% to $119.8 million in 2022, then slumped by 32.88% to $80.4 million in 2023, then skyrocketed by 250.79% to $282.0 million in 2024.